GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Traditional Chinese Medicine Holdings Co Ltd (HKSE:00570) » Definitions » Debt-to-Revenue

China Traditional Chinese Medicine Holdings Co (HKSE:00570) Debt-to-Revenue : 0.29 (As of Dec. 2023)


View and export this data going back to 1993. Start your Free Trial

What is China Traditional Chinese Medicine Holdings Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

China Traditional Chinese Medicine Holdings Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$3,248 Mil. China Traditional Chinese Medicine Holdings Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$2,396 Mil. China Traditional Chinese Medicine Holdings Co's annualized Revenue for the quarter that ended in Dec. 2023 was HK$19,292 Mil. China Traditional Chinese Medicine Holdings Co's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.29.


China Traditional Chinese Medicine Holdings Co Debt-to-Revenue Historical Data

The historical data trend for China Traditional Chinese Medicine Holdings Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Traditional Chinese Medicine Holdings Co Debt-to-Revenue Chart

China Traditional Chinese Medicine Holdings Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.40 0.35 0.27 0.35 0.29

China Traditional Chinese Medicine Holdings Co Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.61 0.30 0.38 0.29

Competitive Comparison of China Traditional Chinese Medicine Holdings Co's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, China Traditional Chinese Medicine Holdings Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Traditional Chinese Medicine Holdings Co's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Traditional Chinese Medicine Holdings Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where China Traditional Chinese Medicine Holdings Co's Debt-to-Revenue falls into.



China Traditional Chinese Medicine Holdings Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

China Traditional Chinese Medicine Holdings Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(3247.801 + 2396.244) / 19821.309
=0.28

China Traditional Chinese Medicine Holdings Co's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(3247.801 + 2396.244) / 19291.862
=0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2023) Revenue data.


China Traditional Chinese Medicine Holdings Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of China Traditional Chinese Medicine Holdings Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


China Traditional Chinese Medicine Holdings Co (HKSE:00570) Business Description

Traded in Other Exchanges
Address
288 Hennessy Road, Room 1601, Emperor Group Centre, Wanchai, Hong Kong, HKG
China Traditional Chinese Medicine Holdings Co Ltd is engaged in the Chinese healthcare sector. The company functions through five segments, finished drugs; concentrated TCM granules; TCM decoction pieces; TCM healthcare complex, and Local TCM integrated operation. It generates maximum revenue from the concentrated TCM granules segment. Geographically, it derives a majority of its revenue from Mainland China.

China Traditional Chinese Medicine Holdings Co (HKSE:00570) Headlines

No Headlines